Renaissance Technologies
GENE

Renaissance Technologies’s Genetic Technologies Ltd. GENE Stock Holding History

Renaissance Technologies’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,233
Closed -$242K – 3780
2020
Q2 		$242K Sell
21,233
-11,388
-35% -$116K ﹤0.01% 3109
2020
Q1 		$321K Buy
32,621
+6,559
+25% +$104K ﹤0.01% 2951
2019
Q4 		$259K Buy
26,062
+3,523
+16% +$34.4K ﹤0.01% 3104
2019
Q3 		$214K Buy
22,539
+1,599
+8% +$17.8K ﹤0.01% 3126
2019
Q2 		$247K Buy
20,940
+1,050
+5% +$16.2K ﹤0.01% 3246
2019
Q1 		$354K Sell
19,890
-845
-4% -$14K ﹤0.01% 3049
2018
Q4 		$227K Sell
20,735
-8,548
-29% -$177K ﹤0.01% 3104
2018
Q3 		$638K Sell
29,283
-12,813
-30% -$291K ﹤0.01% 2772
2018
Q2 		$833K Sell
42,096
-7,053
-14% -$167K ﹤0.01% 2667
2018
Q1 		$1.02M Sell
49,149
-80
-0.2% -$2.31K ﹤0.01% 2652
2017
Q4 		$1.14M Sell
49,229
-235
-0.5% -$4.42K ﹤0.01% 2609
2017
Q3 		$841K Buy
49,464
+2,355
+5% +$39.2K ﹤0.01% 2628
2017
Q2 		$849K Buy
47,109
+5,240
+13% +$110K ﹤0.01% 2621
2017
Q1 		$1M Buy
41,869
+7,915
+23% +$180K ﹤0.01% 2542
2016
Q4 		$733K Buy
33,954
+9,620
+40% +$267K ﹤0.01% 2653
2016
Q3 		$857K Buy
24,334
+4,160
+21% +$169K ﹤0.01% 2636
2016
Q2 		$843K Buy
20,174
+4,455
+28% +$205K ﹤0.01% 2602
2016
Q1 		$726K Sell
15,719
-155
-1% -$6.75K ﹤0.01% 2725
2015
Q4 		$851K Sell
15,874
-3,315
-17% -$167K ﹤0.01% 2537
2015
Q3 		$683K Sell
19,189
-11,350
-37% -$609K ﹤0.01% 2530
2015
Q2 		$1.86M Sell
30,539
-2,000
-6% -$168K ﹤0.01% 2110
2015
Q1 		$3.43M Buy
32,539
+29,599
+1,007% +$2.42M 0.01% 1608
2014
Q4 		$113K Buy
2,940
+1,852
+170% +$74.2K ﹤0.01% 2788
2014
Q3 		$62K Buy
1,088
+908
+504% +$70.9K ﹤0.01% 2701
2014
Q2 		$19K Buy
+180
New +$21.5K ﹤0.01% 2741

Other funds holding GENE

SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Renaissance Technologies's GENE Position: Q3 2020 in Review

Renaissance Technologies sold out of Genetic Technologies Ltd. (GENE) in Q3 2020, closing a stake of 21,233 shares — an estimated $242K sold.

Renaissance Technologies first reported a position in GENE in Q2 2014 and held it in 25 quarters. The position peaked at $3.43M in Q1 2015. 12 funds tracked by Wall St. Rank hold GENE as of Q3 2020.

  • Renaissance Technologies reported no remaining Genetic Technologies Ltd. position as of Q3 2020 after selling out during the quarter.
  • Renaissance Technologies sold 21,233 Genetic Technologies Ltd. shares in Q3 2020, an estimated $242K.
  • Renaissance Technologies first reported a position in Genetic Technologies Ltd. in Q2 2014 and held it in 25 quarters.
  • Renaissance Technologies's Genetic Technologies Ltd. position peaked at $3.43M in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2020.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.